Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells

International Journal of Cancer

Volumn 118, Issue 3, 2006, Pages 571-576

  Kuniyasu, Hiroki ^a,c   Yoshida, Kazuhiro ^b   Sasaki, Takamitsu ^a   Sasahira, Tomonori ^a   Fujii, Kiyomu ^a   Ohmori, Hitoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Conjugated linoleic acid; Gastrointestinal cancer; Peritoneal metastasis; PPAR

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COLLAGEN TYPE 4; CONJUGATED LINOLEIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BAX; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; COLON CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; METASTASIS INHIBITION; MOUSE; NONHUMAN; PERITONEUM METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL RATE; WEIGHT GAIN;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAPERITONEAL; LINOLEIC ACIDS, CONJUGATED; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PERITONEAL NEOPLASMS; PPAR GAMMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 30444440866     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21368     Document Type: Article

References (29)

1. Belury MA. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 2002;132:2995-8.
2. Miller A, Stanton C, Devery R. Cis 9, trans 11- and trans 10, cis 12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells. Anticancer Res 2002;22:3879-87.
3. Gupta RA, Duboi RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001;1:11-21.
4. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 1997;57:3465-70.
5. Chang WC, Chapkin RS, Lupton JR. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 1997;18:721-30.
6. Reddy BS, Burill C, Rigotty J. Effect of diets high in ω-3 and ω-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991;51:487-491.
7. Zhou S, Wang G, Chen B, Wang P. Effect of dietary fatty acids on tumorigenesis of colon cancer induced by methyl nitrosourea in rats. J Environ Pathol Toxicol Oncol 2000;19:81-6.
8. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 2001;61:1927-33.
9. McCarty MF. Activation of PPARγ may mediate a portion of the anticancer activity of conjugated linoleic acid. Med Hypotheses 2000;55:187-8.
10. Moya-Camarena SY, Belury MA. CLA and PPARγ activation. J Nutr 1999;129:2106.
11. Wolf G. The function of the nuclear receptor peroxisome proliferator-activated receptor delta in energy homeostasis. Nutr Rev 2003;61:387-90.
12. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H. Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 2003;124:361-7.
13. Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor γ. Cancer Res 2004;64:1181-9.
14. Terashita Y, Sasaki H, Haruki N, Nishiwaki T, Ishiguro H, Shibata Y, Kudo J, Konishi S, Kato J, Koyama H, Kimura M, Sato A, Shinoda N, Kuwabara Y, Fujii Y. Decreased peroxisome proliferator-activated receptor γ gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 2002;32:238-43.
15. Sugarbaker PH. New responsibilities in the management of colorectal cancer with peritoneal seeding. Cancer Invest 2002;20:1118-22.
16. Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003;21:233-48.
17. Vogel I, Kalthoff H. Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 2001;439:109-17.
18. Kuniyasu H, Yasui W, Kitahara K, Naka K, Yokozaki H, Akama Y, Hamamoto T, Tahara H, Tahara E. Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. Cell Growth Diff 1997;8:47-52.
19. Berger J, Wagner JA. Physiological and therapeutic roles of peroxisome proliferator-activated receptors. Diabetes Technol Ther 2002;4:163-74.
20. Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription? Biochem Pharmacol 2002;64:893-901.
21. Changhua L, Jindong Y, Defa L, Lidan Z, Shiyan Q, Jianjun X. Conjugated linoleic Acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide. J Nutr 2005;135:239-44.
22. Bren-Mattison Y, Van Putten V, Chan D, Winn R, Geraci M. W, Nemenoff RA. Peroxisome proliferator-activated receptor-γ (PPARγ) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC). Oncogene 2004;20:20.
23. Yoshizumi T, Ohta T, Ninomiya I, Terada I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Yi S, Miwa K. Thiazolidinedione, a peroxisome proliferator-activated receptor-γ ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Int J Oncol 2004;25:631-9.
24. Galusca B, Dumollard JM, Chambonniere ML, Germain N, Prades JM, Peoc'h M, Estour B. Peroxisome proliferator activated receptor γ immunohistochemical expression in human papillary thyroid carcinoma tissues: possible relationship to lymph node metastasis. Anticancer Res 2004;24:1993-7.
25. Liu H, Zang C, Fenner MH, Possinger K, Elstner E. PPARγ ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast Cancer Res Treat 2003;79:63-74.
26. Chen A, Xu J. Activation of PPARγ by curcumin inhibits Moser cell growth and mediates the suppression of the gene expression of cyclinD1 and EGFR. Am J Physiol Gastrointest Liver Physiol 2004;14:14.
27. Liu JJ, Huang RW, Lin DJ, Peng J, Wu XY, Lin Q, Pan XL, Song YQ, Zhang MH, Hou M, Chen F. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-γ ligands induces apoptosis on human myeloid leukemia cells in vitro. Ann Oncol 2005;10:10.
28. Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I, Heys SD. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. Faseb J 2002;16:1447-9.
29. Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 2002;22:505-31.